Ljubljana bourse indices advance, Krka gains most
Croatia’s main equity indices edge higher, turnover drops
Romanian stock close mixed in higher turnover
Romanian c-bank likely to hold key rate at 7% - Erste
Most Sofia bourse indices rise, Sopharma paces gainers
Sep 26, 2019 10:48 EEST
September 26 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev has acquired 21,699 shares in the company at a weighted average price per share of 3.4407 levs ($1.93/1.76 euro).
Donev acquired the shares through deals on the Bulgarian Stock Exchange on September 25, Sopharma said in a bourse filing.
The 21,699 shares are equal to a 0.016% stake in Sopharma.
Donev has been actively acquiring small packages of Sopharma shares since the start of September. Since then, Donev has made only one sale, of 3,620 shares.
At the end of June, Donev held a stake of below 5% in Sopharma, according to the company's most recent interim financial statement.
However, Ognyan Donev is indirectly the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 8:30 CET on Thursday, Sopharma shares traded 2.90% lower at 3.35 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get two (2) free articles more per month or sign up for
and get unlimited access.
Browse our free newsletter options